Trials / Withdrawn
WithdrawnNCT01053702
Study of the Safety and Efficacy of REGN475(SAR164877) in Patients With Pain Resulting From Thermal Injury
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Regeneron Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, double-blind, placebo-controlled, parallel-group, single-dose study of the efficacy of REGN475 in patients with pain due to thermal injury.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | R475 | IV |
| DRUG | Placebo | Placebo |
Timeline
- First posted
- 2010-01-21
- Last updated
- 2011-04-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01053702. Inclusion in this directory is not an endorsement.